LSE - Delayed Quote USD
Xylem Inc. (0M29.L)
127.19
-0.16
(-0.13%)
As of June 4 at 5:58:54 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 21 | 21 |
| Avg. Estimate | 2.2B | 2.17B | 8.75B | 9.17B |
| Low Estimate | 2.17B | 2.09B | 8.54B | 8.69B |
| High Estimate | 2.24B | 2.21B | 8.83B | 9.34B |
| Year Ago Sales | 2.17B | 2.1B | 8.56B | 8.75B |
| Sales Growth (year/est) | 1.51% | 3.17% | 2.19% | 4.85% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0M29.L | -- | -- | -- | -- |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
| Initiated | JP Morgan: Overweight | 5/30/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 4/30/2025 |
| Maintains | Stifel: Buy to Buy | 4/30/2025 |
| Maintains | Baird: Outperform to Outperform | 4/30/2025 |
| Maintains | Stifel: Buy to Buy | 4/16/2025 |
| Maintains | Citigroup: Buy to Buy | 4/14/2025 |